Sands Capital Life Sciences Pulse Fund III, L.P. — Form D
Sands Capital Life Sciences Pulse Fund III, L.P. of ARLINGTON, VA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-03-25. $8.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-03-25
- Form: D
- Accession: 0001981605-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Amount sold: $8.0M
- Investors: 1
- Date of first sale: 2025-03-14
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-542119
Issuer
- Name: Sands Capital Life Sciences Pulse Fund III, L.P.
- CIK: 0001981605
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2023
- Address: C/O SANDS CAPITAL VENTURES, LLC, ARLINGTON, VA, 22209
- Phone: 703-562-4000
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Jonathan Goodman | Executive Officer | Arlington, VA |
| Erin Soule | Executive Officer | Arlington, VA |
Other filings by this issuer (1)
More